Delhi High Court Dismisses CGHS Medicine Tender Challenge as Premature; Directs Authorities to Evaluate Discount Justifications and Pass Reasoned Decisions Before Any Further Challenge
Delhi High Court Permits CGHS to Continue Scrutiny of Medicine Discounts; Holds Commercial Justification Notice Alone Does Not Violate Bidders’ Rights
Facts
The Delhi High Court decided four connected writ petitions filed by Prakash Medicos and A.S. Enterprises against various zones of the Central Government Health Scheme (CGHS). The petitions arose from tenders floated on 18 March 2026 for empanelment of “Authorised Local Chemists” to supply branded medicines and surgical consumables.
The petitioners were declared technically qualified, and the financial bids were opened on 9 July 2026. Thereafter, on 24 July 2026, the concerned Additional Directors of CGHS issued communications to technically qualified bidders requiring them to submit commercial justification for the discounts quoted in their bids, along with supporting material, so that allegedly abnormally low bids could be identified and disallowed.
The petitioners questioned the standard contained in the communication, contending that concepts such as “commonly prescribed branded medicines” were vague and undefined. They nevertheless uploaded the information and supporting documents sought by CGHS on the GeM portal on 25/26 July 2026.
Their principal grievance was that the methodology adopted by CGHS to identify predatory or commercially unsustainable discounts lacked objective and verifiable standards.
The respondents maintained that the tender evaluation process was still ongoing, no bid had been rejected or disqualified, and no final decision had been taken.
Issues
The principal issues before the High Court were:
- Whether the writ petitions were maintainable at an intermediate stage of the tender process when no final bid decision had yet been taken.
- Whether the CGHS communication dated 24 July 2026 seeking commercial justification for quoted discounts caused any present legal prejudice to the petitioners.
- Whether the alleged vagueness surrounding “commonly prescribed branded medicines” justified immediate judicial interference.
- Whether CGHS could seek supporting documents and commercial justification to test the sustainability of quoted discounts.
- Whether the petitioners should first await a reasoned decision from the tender authority before invoking judicial review.
Petitioners’ Arguments
The petitioners argued that although Clause 4.1(C) and Clause 7.1 of the Scope of Work sought to prevent predatory pricing, the process created by the communication dated 24 July 2026 was vague, arbitrary and discriminatory.
They contended that the expression “commonly prescribed branded medicines” had not been defined through any objective standard.
According to them, CGHS ought to have prescribed an ascertainable benchmark, possibly linked to market share or the top 500 brands supplied in Delhi-NCR wellness centres.
They further submitted that it was unclear whether bidders were expected to provide information regarding:
- commonly prescribed medicines across brands; or
- commonly prescribed brands within different medicine categories.
The absence of such clarity, according to the petitioners, made meaningful evaluation impossible.
They also argued that discounts above approximately 25%–30% of MRP were commercially impossible and therefore predatory.
Respondents’ Arguments
CGHS contended that the writ petitions were premature because the tender process had not reached a final stage.
No bidder had been declared unsuccessful, no bid had been rejected, no disqualification had occurred and no contract had yet been awarded.
The communication dated 24 July 2026 merely required technically qualified bidders to provide commercial justification and documents so that CGHS could assess the sustainability of their quoted discounts.
According to the respondents, the exercise was intended to prevent future disruption in medicine supplies and to protect public health by ensuring that accepted bids were commercially viable.
CGHS also rejected the petitioners’ assumption that discounts above 25%–33% were inherently unsustainable.
It pointed out that market discounts may vary depending on:
- bulk procurement arrangements;
- manufacturer tie-ups;
- institutional supply contracts; and
- other commercial factors.
The Financial Evaluation Committee was therefore entitled to examine purchase invoices and commercial agreements to assess viability.
The respondents also assured the Court that the documents furnished by the petitioners would be considered in accordance with the tender conditions and applicable procurement norms.
Intervenors’ Arguments
The successful or higher-ranked intervening bidders argued that the petitioners were effectively attempting to change the rules of the tender after participating in it.
They pointed out that the petitioners had not emerged as H1 bidders in any CGHS wellness centre, whereas some intervenors had emerged successful in multiple centres.
The intervenors further argued that the challenged communication applied uniformly to all technically qualified bidders and did not accept or reject any particular bid.
They therefore characterised the petitions as speculative and premature.
It was also asserted that discounts in institutional pharmaceutical procurement cannot be assessed merely by reference to retail margins because bidders may blend different margins across a broad spectrum of medicines and consumables.
Analysis of the Law
No Final Tender Decision Had Been Taken
The Court treated the absence of a final decision as decisive.
The impugned communication did not reject or disqualify the petitioners.
It simply sought further commercial justification regarding the discounts quoted.
Accordingly, no adverse determination affecting the petitioners’ rights had yet crystallised.
The Court therefore agreed with CGHS that judicial intervention at that stage would be premature.
Tender Authority Must Be Allowed to Complete Evaluation
The High Court held that CGHS should first be permitted to complete the bid evaluation process on the basis of the information and documents already sought and supplied.
The Court declined to adjudicate the petitioners’ substantive objections to the methodology before the competent tender authority itself had applied that methodology and reached a conclusion.
This reflects the settled judicial reluctance to interfere with tender processes at an intermediate evaluative stage absent an actual adverse decision.
Commercial Sustainability Inquiry Was Not Itself Illegal
The judgment did not hold that CGHS’s methodology was necessarily correct.
Instead, the Court declined to pronounce on that question prematurely.
It accepted that the communication was intended to test whether quoted discounts were commercially sustainable and whether accepting them might later lead to disruption in the supply of medicines.
Thus, the mere act of asking bidders to justify unusually high discounts did not itself create a legally actionable wrong.
Reasoned Decision Required
Although the Court declined interference, it imposed an important procedural requirement.
CGHS was directed to:
- consider the responses and supporting documents furnished by the bidders;
- evaluate the bids on that basis;
- take a reasoned decision; and
- communicate that decision to the concerned bidders.
This preserved transparency and ensured that any eventual rejection or acceptance could be judicially reviewed on an intelligible record.
Right to Challenge Final Decision Preserved
The Court expressly clarified that any bidder aggrieved by the eventual reasoned decision would remain free to pursue whatever remedy is available in law.
Thus, the petitions failed because of timing, not because the Court conclusively validated every aspect of CGHS’s evaluation methodology.
Precedent Analysis
Afcons Infrastructure Ltd. v. Nagpur Metro Rail Corporation Ltd.
The respondents relied on this authority for the principle that courts ordinarily defer to the interpretation adopted by the author of a tender document unless the interpretation is manifestly arbitrary, mala fide or perverse.
Silppi Constructions Contractors v. Union of India
This precedent was relied upon for the narrow scope of judicial review in tender matters and the need for restraint where the tender process is still ongoing.
Agmatel India Pvt. Ltd. v. Resoursys Telecom
The respondents also invoked this decision to emphasise that the tendering authority is ordinarily best placed to interpret technical or commercial tender requirements.
E Trav Tech Limited v. Union of India
The petitioners relied upon this Delhi High Court judgment to contend that intervention could still be sought where the tender methodology itself was allegedly arbitrary, even before the process had fully concluded.
The present Bench, however, did not consider it necessary to enter into the merits because no final decision had yet been taken.
Court’s Reasoning
The Court adopted a deliberately limited approach.
It recognised that the petitioners had objections regarding the alleged vagueness of the commercial justification exercise.
However, those objections were raised before CGHS had actually completed evaluation or taken any adverse action.
The petitioners had already submitted the requested responses and documents.
Therefore, the appropriate course was not for the High Court to pre-empt the tender authority’s determination, but to require CGHS to evaluate the material and issue a reasoned decision.
Only thereafter, if any bidder suffered prejudice, would a mature cause of action arise for judicial review.
Conclusion
The Delhi High Court held that the connected writ petitions were premature because the CGHS tender evaluation process was still underway and no bidder had yet been rejected or disqualified.
The Court accordingly declined to examine the substantive challenge to the 24 July 2026 communication at that stage.
CGHS was directed to consider the responses and documents submitted by the bidders, take a reasoned decision on the bids, and communicate the same to the concerned parties.
Any bidder aggrieved by that eventual decision was left free to pursue remedies available in law.
The petitions and pending applications were accordingly disposed of with no order as to costs.
Case Details
Case: Prakash Medicos v. Additional Director CGHS South Zone & Ors., with connected petitions
Court: Delhi High Court
Case Numbers: W.P.(C) 10449/2026, W.P.(C) 10450/2026, W.P.(C) 10451/2026 and W.P.(C) 10452/2026
Judges: Justice V. Kameswar Rao and Justice Manmeet Pritam Singh Arora
Date: 14 August 2026
Result: Petitions disposed of as premature; CGHS directed to evaluate bidders’ commercial justifications, pass reasoned decisions and communicate them, with liberty to aggrieved bidders to challenge thereafter.
